What initial evaluation and empiric treatment should be recommended for a 61-year-old man presenting with crampy abdominal pain without tenderness and increased bowel frequency?

Initial Evaluation and Empiric Treatment for Crampy Abdominal Pain with Increased Bowel Frequency

This 61-year-old man with crampy abdominal pain without tenderness and increased bowel frequency most likely has IBS-D (irritable bowel syndrome with diarrhea), and should receive initial blood work (CBC, CRP/ESR, coeliac serology, fecal calprotectin) followed by empiric treatment with antispasmodics for pain and loperamide for diarrhea control. 1

Diagnostic Approach

Essential Initial Testing

The British Society of Gastroenterology 2021 guidelines mandate specific blood and stool tests before making a positive IBS diagnosis 1:

• Complete blood count (to exclude anemia)
• C-reactive protein or ESR (to screen for inflammation)
• Coeliac serology (celiac disease can mimic IBS)
• Fecal calprotectin (in patients <45 years with diarrhea to exclude inflammatory bowel disease - though this patient is 61, still reasonable given diarrhea-predominant symptoms)

The absence of alarm features (no tenderness, no weight loss implied, no rectal bleeding) combined with the classic symptom pattern allows for a positive clinical diagnosis of IBS-D once these basic tests are normal. 1

Key Clinical Features Supporting IBS-D

The cramping quality of pain with increased bowel frequency without peritoneal signs (no tenderness) is the hallmark presentation of functional abdominal cramping pain, specifically IBS-D 2. The absence of tenderness is particularly reassuring against acute surgical conditions.

Empiric Treatment Strategy

First-Line Pharmacological Management

1. Antispasmodics for Cramping Pain

Antispasmodics should be the primary treatment for the cramping abdominal pain 3, 1. The 2022 AGA and 2021 BSG guidelines both recommend antispasmodics as first-line therapy, showing:

• Significant improvement in global IBS symptoms (RR 0.67; 95% CI 0.55-0.80)
• Reduction in abdominal pain (RR 0.74; 95% CI 0.59-0.93) 3

Available options in the US include:

• Hyoscine (hyoscyamine)
• Dicyclomine
• Peppermint oil

Start with low doses and titrate up to minimize anticholinergic side effects (dry mouth, dizziness, blurred vision). 1

2. Loperamide for Diarrhea Control

For the increased bowel frequency, loperamide is recommended 3, 1. The 2022 AGA guidelines suggest using loperamide in IBS-D patients, showing:

• Improvement in stool consistency (RR 0.06; 95% CI 0.01-0.43)
• Adequate relief of abdominal pain (RR 0.41; 95% CI 0.20-0.84) 3

Dose titration is critical - start low and adjust based on stool frequency patterns. Can be used as-needed, daily, or after a certain number of loose stools depending on symptom patterns. 3

Second-Line Options if First-Line Fails

Tricyclic Antidepressants (TCAs)

If symptoms persist after 4 weeks of antispasmodics and loperamide, consider adding a TCA 3. TCAs work as gut-brain neuromodulators affecting motility, secretion, and visceral sensation - not just mood. The AGA suggests using TCAs in IBS patients (conditional recommendation, low certainty evidence). 3

Important caveat: SSRIs are NOT recommended - the AGA specifically suggests against using SSRIs for IBS as they did not significantly improve global symptoms or abdominal pain. 3

Dietary Modifications

First-Line Dietary Advice

• Soluble fiber (ispaghula) is effective for global symptoms and abdominal pain
• Start at 3-4 g/day and build up gradually to avoid bloating
• Avoid insoluble fiber (wheat bran) as it may worsen symptoms 1

Second-Line: Low FODMAP Diet

If symptoms persist despite medication and basic dietary advice, refer to a specialist dietitian for a low FODMAP diet 1. This requires careful implementation and monitoring to avoid nutritional deficiencies and overly restrictive eating patterns.

Critical Pitfalls to Avoid

1. Do not pursue extensive imaging or endoscopy if basic blood/stool tests are normal and no alarm features exist - this increases costs without benefit and reinforces illness behavior 4

2. Do not use SSRIs for IBS symptom control - they are ineffective for this indication despite being commonly prescribed 3

3. Avoid repetitive testing once functional diagnosis is established - this wastes resources and increases patient anxiety 4

4. Screen for eating disorders before recommending restrictive diets using tools like SCOFF questionnaire 1

When to Refer to Gastroenterology

Referral is warranted if 1:

• Diagnostic uncertainty persists
• Symptoms are severe or refractory to first-line treatments
• Patient specifically requests specialist opinion
• Alarm features develop (weight loss, rectal bleeding, anemia, elevated inflammatory markers)

The key principle is making a positive diagnosis based on symptoms rather than extensive exclusionary testing, then implementing a stepwise treatment algorithm starting with antispasmodics and loperamide. 1